Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Saada Diab"'
Publikováno v:
HemaSphere, Vol 7, p e847207f (2023)
Externí odkaz:
https://doaj.org/article/a78db6999a7440ecb93be7f07165b91d
Publikováno v:
HemaSphere, Vol 7, p e127741a (2023)
Externí odkaz:
https://doaj.org/article/9bf80c982b2c4eedb8d5f26096acd6f6
Publikováno v:
HemaSphere, Vol 7, p e96141fe (2023)
Externí odkaz:
https://doaj.org/article/aebd0d067d4c40a186d0da3561a344a0
Autor:
Fadi Nasr, Ahmad Al Ghoche, Roland Eid, Lewis Nasr, Saada Diab, Souheil Hallit, Moussa Riachi
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 2, Pp 421-425 (2019)
Stage III non-small cell lung cancer is a border line stage between localized and metastatic disease. PDL-1 is gaining an important role in the therapeutic arsenal of lung cancer, the most frequent cancer worldwide. We report for the first time a neg
Externí odkaz:
https://doaj.org/article/608cf2e8ecd84e029ec96f4884b19899
Autor:
Fadi Nasr, Ahmad Al Ghoche, Saada Diab, Lewis Nasr, Emmanuel Ammanouil, Christelle Riachy, Souheil Hallit, Georges Chahine
Publikováno v:
Leukemia Research Reports, Vol 15, Iss , Pp 100252- (2021)
OBJECTIVE: The present retrospective multicenter study aims at documenting characteristics of multiple myeloma (MM) patients and the effect of autologous stem cell transplant (ASCT) on survival. METHODS: A total of 134 adult patients initiating any n
Externí odkaz:
https://doaj.org/article/bc6692a825974af28f3d665732811dfc
Autor:
Saada Diab, Roland Eid, Fadi Nasr, Lewis Nasr, Moussa Riachi, Ahmad Al Ghoche, Souheil Hallit
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 2, Pp 421-425 (2019)
Case Reports in Oncology
Case Reports in Oncology
Stage III non-small cell lung cancer is a border line stage between localized and metastatic disease. PDL-1 is gaining an important role in the therapeutic arsenal of lung cancer, the most frequent cancer worldwide. We report for the first time a neg
Publikováno v:
Journal of Medical Cases. 10:62-65
Publikováno v:
Journal of Thoracic Oncology. 16:S1004-S1005
Publikováno v:
Journal of Clinical Oncology. 40:e19512-e19512
e19512 Background: Many advances in the treatment of chronic lymphocytic leukemia (CLL) has been made in the 6 past years aiming at attaining durable complete responses and even cure. The choice of upfront therapy is driven by several factors includi
Publikováno v:
Journal of Clinical Oncology. 40:e18741-e18741
e18741 Background: Immunotherapy provides improved treatment efficacy and survival in NSCLC patients. This is well established from clinical trials. However, the effectiveness of immunotherapy in real world practice is not well assessed. We aimed to